Prospective Registry of ADC as First- and Second-line Treatment for Breast Cancer

Clinical trial NCT06774027 · RECRUITING

Trial details

NCT number: NCT06774027
Sponsor: University of California, San Francisco
Status: RECRUITING
Study type: OBSERVATIONAL

HER2-negative Breast Cancer HER2 Negative Breast Carcinoma Metastatic Breast Cancer HR+ HER2 Breast Cancer Metastatic Triple Negative Breast Cancers Metastatic Triple-Negative Breast Carcinoma

Start date: 2025-10-08
Primary completion: 2030-12-31
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.